Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yuexin Xu"'
Autor:
David G. Coffey, Yuexin Xu, Andrea M. H. Towlerton, Marcin Kowanetz, Priti Hegde, Martine Darwish, Mahesh Yadav, Craig Blanchette, Shannon M. Ruppert, Sarah Bertino, Qikai Xu, Andrew Ferretti, Adam Weinheimer, Matthew Hellmann, Angel Qin, Dafydd Thomas, Edus H. Warren, Nithya Ramnath
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Most patients with advanced non-small cell lung cancer (NSCLC) do not achieve a durable remission after treatment with immune checkpoint inhibitors. Here we report the clinical history of an exceptional responder to radiation and anti-program death-l
Externí odkaz:
https://doaj.org/article/0ad62252e9ae47dfa7add7911dd39d72
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
In renal-cell carcinoma (RCC), tumor-reactive T-cell responses can occur spontaneously or in response to systemic immunotherapy with cytokines and immune checkpoint inhibitors. Cancer vaccines and engineered T-cell therapies are designed to selective
Publikováno v:
Cancer Immunology Research. 8:A36-A36
Purpose: T-cell infiltration of renal cell carcinoma (RCC) is commonly viewed as evidence for antitumor immunity that may be harnessed by T cell-directed immunotherapies. We hypothesize that bona fide tumor-reactive T cells constitute only a fraction
Autor:
Young-Min Hyun, Seyeon Bae, Kihong Lim, Minsoo Kim, Edith M. Lord, Scott A. Gerber, Ryan J. Cummings, Hyunwook Lee, Yuexin Xu, Thomas Yoonsang Cho
Publikováno v:
Proceedings of the National Academy of Sciences. 111:6371-6376
Adoptive cell transfer of ex vivo-generated immune-promoting or tolerogenic T cells to either enhance immunity or promote tolerance in patients has been used with some success. However, effective trafficking of the transferred cells to the target tis